Terminated
A Study of LY3127804 in Participants With COVID-19
I7W-MC-UDAA - ClinicalTrials.gov - NCT04342897
This study is a randomized, double-blind, placebo-controlled, clinical trial designed to evaluate LY3127804 in participants who are hospitalized with pneumonia and presumed or confirmed COVID-19.
How long will I be in the trial?
The study may last up to 9 weeks and include daily visits up to day 28, and follow-up visits by phone.
Terminated
A Study of LY3127804 in Participants With COVID-19
I7W-MC-UDAA - ClinicalTrials.gov - NCT04342897
This study is a randomized, double-blind, placebo-controlled, clinical trial designed to evaluate LY3127804 in participants who are hospitalized with pneumonia and presumed or confirmed COVID-19.
How long will I be in the trial?
The study may last up to 9 weeks and include daily visits up to day 28, and follow-up visits by phone.
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must be admitted to the hospital for less than 48 hours with respiratory involvement
Participants must have confirmed pneumonia
Participants must have presumed or confirmed COVID-19
Participants must NOT
Participants must not have Acute Respiratory Distress Syndrome (ARDS) or require immediate ventilation, or be ineligible for ventilation
Participants must not have any serious medical condition or medication that prevents participation
Participants must not be at the point of death
Participants must not have had recent major surgery
Participants must not have had recent blood clots or events like heart attack
Participants must not have congestive heart failure or irregular heartbeat
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
LY3127804, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
210
Trial Dates
April 2020 - October 2020
Trial Phase
2
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must be admitted to the hospital for less than 48 hours with respiratory involvement
Participants must have confirmed pneumonia
Participants must have presumed or confirmed COVID-19
Participants must NOT
Participants must not have Acute Respiratory Distress Syndrome (ARDS) or require immediate ventilation, or be ineligible for ventilation
Participants must not have any serious medical condition or medication that prevents participation
Participants must not be at the point of death
Participants must not have had recent major surgery
Participants must not have had recent blood clots or events like heart attack
Participants must not have congestive heart failure or irregular heartbeat
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
LY3127804, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
210
Trial Dates
April 2020 - October 2020
Trial Phase
2
Not the right fit? Sign up to receive updates on new COVID-19 (Coronavirus) trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
By clicking the checkbox and using the map, you agree to allow Google Maps to collect your personal information in accordance with their Privacy Policy
COVID-19 (Coronavirus) Resources
COVID-19 Research
COVID-19 is caused by SARS-CoV-2, a novel coronavirus. Because it is a relatively new disease, scientists and physicians do not know much about it, and currently, there are not many medicines to treat it. That’s why we need clinical research—to test potential new treatments for COVID-19. Read on to see if a clinical trial may be right for you.
